Genix Pharmaceuticals Corp
XTSX:GENX
Genix Pharmaceuticals Corp
XTSX:GENX
Price:
0.015
CAD
-25%
Market Closed
Market Cap:
CA$918.3k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Genix Pharmaceuticals Corp
XTSX:GENX
|
CA |
|
Zug Estates Holding AG
F:ZEE
|
CH |
|
United Spirits Ltd
NSE:UNITDSPR
|
IN |
|
Priority Technology Holdings Inc
NASDAQ:PRTH
|
US |
|
Embecta Corp
F:JX7
|
US |
|
Sixt SE
F:SIX3
|
DE |
|
Merdeka Copper Gold Tbk PT
F:B0C
|
ID |
|
Reckitt Benckiser Group PLC
OTC:RBGPF
|
UK |
|
V
|
Vistance Networks Inc
XMUN:CM9
|
US |
|
S
|
Shangri-La Hotel PCL
SET:SHANG
|
TH |
|
Pointerra Ltd
ASX:3DP
|
AU |
|
Y
|
Yum! Brands Inc
F:TGR
|
US |
|
B
|
biote Corp
NASDAQ:BTMD
|
US |
Intrinsic Value
Not Available for GENX
There is not enough data to reliably calculate the intrinsic value for Genix Pharmaceuticals Corp.
Do our valuations actually work? See backtest results .
Alternatives to GENX
Fundamental Analysis
What Genix Pharmaceuticals Does
Genix Pharmaceuticals Corp. engages in the the research, development, manufacture, licensing and sales of novel and innovative healthcare products, particularly proprietary over the counter nutraceuticals and generic pharmaceuticals. The company is headquartered in Vancouver, British Columbia. The firm is a formulator, manufacturer, licensor and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals.
- Headquarters
- Canada CA
- IPO date
- Jun 25, 1996
Financials
Revenue & Expenses Breakdown
Genix Pharmaceuticals Corp
Genix Pharmaceuticals Corp
Efficiency
Earnings Waterfall
Genix Pharmaceuticals Corp
Genix Pharmaceuticals Corp
